Hendrik Runge

Serial entrepreneur with demonstrated track record of earliest-stage company building and fundraising. Currently commercialising cutting-edge RNA analysis tools at Cambridge Nucleomics, previously healthcare accelerator Start Codon and PhD in Medical Research at Cambridge University on a full scholarship by the Medical Research Council in cancer research (Haematology, Cambridge Stem Cell Institute) under the supervision of the ambitious Dr. Daniel Hodson and Prof. Brian Huntly. Hendrik studied the molecular bases of diseases, particularly cancer, in his Molecular Medicine Bachelor and Master from Freiburg, Germany. The interdisciplinary programme enabled him to closely work on multi-disciplinary teams with physicists, bioinformaticians and medical doctors during extensive, independent laboratory projects early on. He started a PhD in Medical Research at Cambridge in 2017 focussing on lymphoma, the commonest bloodborne cancer, and employs cutting edge technologies like CRISPR/Cas9, retr